245 Participants Needed

JUNTOS Referral Network for HIV Prevention and Treatment

NA
AH
JL
Overseen ByJorge Limia, MS
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: University of Miami
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

What is the purpose of this trial?

The objective of this study is to evaluate the JUNTOS Referral Network as an implementation strategy to enhance the reach of HIV-prevention and treatment services to Latino gay, bisexual, and other men who have sex with men (MSM).

Will I have to stop taking my current medications?

The trial information does not specify whether participants need to stop taking their current medications.

What data supports the effectiveness of the JUNTOS treatment for HIV prevention and treatment?

The research highlights the importance of strong connections between general physicians and HIV specialists, which can improve the quality of HIV care. Additionally, optimizing health care systems and engaging physicians in HIV care can enhance treatment outcomes, suggesting that a well-connected referral network like JUNTOS could be effective in improving HIV prevention and treatment.12345

How does the JUNTOS Referral Network treatment for HIV differ from other treatments?

The JUNTOS Referral Network is unique because it focuses on creating a network of services to connect people with HIV to comprehensive care, rather than being a direct medical treatment. It emphasizes linking individuals to existing community resources and services, addressing immediate needs like housing, which can be more appealing and effective for marginalized populations.678910

Research Team

AH

Audrey Harkness, PhD

Principal Investigator

University of Miami

Eligibility Criteria

This trial is for Latino gay, bisexual, and other men who have sex with men (MSM) as part of an effort to improve HIV-prevention and treatment services. Specific eligibility criteria are not provided.

Inclusion Criteria

Reports suboptimal fidelity to pre-exposure prophylaxis (PrEP) referral guidelines (<80% fidelity)
Identifies as Latino/a/x or Hispanic
Lives in Miami-Dade County, Broward County, or Palm Beach County and anticipates living there for the next three months
See 6 more

Exclusion Criteria

I work as an HIV counselor in a prison.
Latino MSM: Unable to consent
HIV test counselors: Unable to consent
See 1 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants access the JUNTOS Referral Network or referral sheet for HIV prevention and treatment services

3 months
Ongoing access through app/website

Follow-up

Participants are monitored for use of biomedical HIV prevention/treatment and HIV status

3 months
Self-report assessments

Extended Follow-up

Continued monitoring of referral fidelity and HIV prevention/treatment engagement

6 months

Treatment Details

Interventions

  • JUNTOS
Trial Overview The study is evaluating the effectiveness of the JUNTOS Referral Network in increasing access to HIV-prevention and treatment services among the target population.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: JUNTOSExperimental Treatment1 Intervention
Participants in this group will get access to the JUNTOS Referral Network website/app through the 6-month follow up (HIV test counselors) and 3-month follow up (Latino MSM).
Group II: Referral Sheet - HIV test counselorsActive Control1 Intervention
Participants in this group will get access to the referral sheet through the 6-month follow up (HIV test counselors) and 3-month follow up (Latino MSM).

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Miami

Lead Sponsor

Trials
976
Recruited
423,000+

National Institute of Mental Health (NIMH)

Collaborator

Trials
3,007
Recruited
2,852,000+

Findings from Research

Generalist physicians who are more connected to HIV specialists show improved quality in prescribing HIV medications, with each additional connection leading to a 1.46 percentage point increase in medication quality for their patients.
Enhancing the network connections between generalists and HIV specialists could potentially reduce annual HIV infections by up to 6%, indicating that collaboration among healthcare providers is crucial for better patient outcomes.
Physician network connections to specialists and HIV quality of care.Stecher, C.[2022]
A study analyzing health resource utilization among people living with HIV in British Columbia identified distinct profiles of care, highlighting differences between those actively involved in non-HIV care and those with minimal healthcare interaction after initial linkage to care.
The findings suggest that tailored reengagement strategies are necessary to improve HIV care, focusing on missed opportunities in non-HIV healthcare and enhancing collaboration with physicians involved in HIV treatment.
Informing Targeted Interventions to Optimize the Cascade of HIV Care Using Cluster Analyses of Health Resource Use Among People Living with HIV/AIDS.Krebs, E., Min, JE., Bayoumi, AM., et al.[2019]
A study of 21,880 HIV-positive individuals in Haiti found that multi-month dispensing (MMD) of antiretroviral therapy significantly improved retention in care, with a 24.2% increase in retention likelihood when extending dispensing intervals by 30 days.
While MMD is effective for new ART recipients, extending dispensing lengths for those already receiving longer supplies may negatively impact retention, indicating the need for careful consideration in treatment plans.
Estimating the effect of increasing dispensing intervals on retention in care for people with HIV in Haiti.Parrish, C., Basu, A., Fishman, P., et al.[2023]

References

Physician network connections to specialists and HIV quality of care. [2022]
Informing Targeted Interventions to Optimize the Cascade of HIV Care Using Cluster Analyses of Health Resource Use Among People Living with HIV/AIDS. [2019]
Estimating the effect of increasing dispensing intervals on retention in care for people with HIV in Haiti. [2023]
A side door into care cascade for HIV-infected patients? [2022]
Factors Associated With Gaps in Medicaid Enrollment Among People With HIV and the Effect of Gaps on Viral Suppression. [2021]
Linking HIV-infected persons of color and injection drug users to HIV medical and other services: the California Bridge Project. [2022]
Potentialities and weaknesses in the care network of people with HIV/AIDS. [2017]
Interorganizational relationships among HIV/AIDS service organizations in Baltimore: a network analysis. [2019]
Characterizing Network-Based HIV Testing Interventions to Guide HIV Testing and Contact Tracing at STI Clinics in Lilongwe, Malawi. [2023]
10.United Statespubmed.ncbi.nlm.nih.gov
Exploring Changes in Interagency Collaboration Following AIDS United's Positive Charge: A Five-Site HIV Linkage and Retention in Care Program. [2018]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of ServiceยทPrivacy PolicyยทCookiesยทSecurity